Skip to main content

Advertisement

Log in

Sparing level Ib lymph nodes by intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

We retrospectively investigated the patterns of locoregional relapse and survival of patients to evaluate whether sparing level Ib lymph nodes by intensity-modulated radiotherapy (IMRT) in the treatment of nasopharyngeal carcinoma was feasible.

Methods

One hundred and twenty nasopharyngeal carcinoma patients received treatment with level Ib lymph nodes spared by IMRT between January 2005 and August 2008 in our center. Before treatment, each patient underwent enhanced magnetic resonance imaging of the nasopharynx and neck. Patients with negative cervical lymph nodes received radiotherapy to the nasopharynx, skull base and upper neck drainage areas, while patients with cervical lymph node involvement received treatment to the whole neck. The prescription doses were 66–70.4 Gy/30–32 fractions to the gross tumor volume of nasopharynx, 66 Gy to the positive neck nodes, 60 Gy to the high-risk clinical target volume and 54 Gy to the low-risk clinical target volume. Patients staged III, IV A/B or II also received chemotherapy.

Results

The median follow-up of these 120 patients was 54 months. The 5-year local control, regional control, distant metastasis-free and overall survival rates were 90.7, 96.5, 84.8 and 81.4 %, respectively. Four patients suffered regional recurrence: 2, 1 and 1 experienced regional recurrence in level II, retropharyngeal and parotid lymph nodes, respectively.

Conclusion

In nasopharyngeal carcinoma patients with negative level Ib lymph nodes who are treated with level Ib-sparing IMRT, regional lymph node recurrence alone is rare. Therefore, sparing level Ib lymph nodes by IMRT is feasible in selected patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

IMRT:

Intensity-modulated radiotherapy

NPC:

Nasopharyngeal carcinoma

SMG:

Submandibular gland

PG:

Parotid gland

References

  1. Milne RW, Dawes C (1973) The relative contributions of different salivary glands to the blood group activity of whole saliva in humans. Vox Sang 25:298–307

    Article  CAS  PubMed  Google Scholar 

  2. Tabak LA (1995) In defense of the oral cavity: structure, biosynthesis, and function of salivary mucins. Annu Rev Physiol 57:547–564

    Article  CAS  PubMed  Google Scholar 

  3. Nutting CM, Morden JP, Harrington KJ et al (2011) Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 12:127–136

    Article  PubMed Central  PubMed  Google Scholar 

  4. Hsiung C, Ting H, Huang H et al (2006) Parotid-sparing intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma: preserved parotid function after IMRT on quantitative salivary scintigraphy, and comparison with historical data after conventional radiotherapy. Int J Radiat Oncol Biol Phys 66:454–461

    Article  PubMed  Google Scholar 

  5. Murdoch-Kinch C, Kim HM, Vineberg KA et al (2008) Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 72:373–382

    Article  PubMed Central  PubMed  Google Scholar 

  6. Zhang Y, Guo CB, Zhang L et al (2012) Prevention of radiation-induced xerostomia by submandibular gland transfer. Head Neck 34:937–942

    Article  PubMed  Google Scholar 

  7. SaIbishkumar EP, Jha N, Scrimger RA et al (2007) Sparing the parotid glands and surgically transferred submandibular gland with helical tomotherapy in post-operative radiation of head and neck cancer: a planning study. Radiother Oncol 85:98–104

    Article  PubMed  Google Scholar 

  8. Collan J, Kapanen M, Mäkitie A et al (2012) Submandibular gland-sparing intensity modulated radiotherapy in the treatment of head and neck cancer: sites of locoregional relapse and survival. Acta Oncol 51:735–742

    Article  PubMed  Google Scholar 

  9. Patricia D, Wilko V, Derek R et al (2011) Sparing the contralateral submandibular gland without compromising PTV coverage by using volumetric modulated arc therapy. Radiat Oncol 6:74

    Article  Google Scholar 

  10. Wolden SL, Chen WC, Pfister DG et al (2006) Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys 64:57–62

    Article  PubMed  Google Scholar 

  11. Lee N, Xia P, Quivey JM et al (2002) Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 53:12–22

    Article  PubMed  Google Scholar 

  12. Kam MK, Teo PM, Chau R et al (2004) Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys 60:1440–1450

    Article  PubMed  Google Scholar 

  13. Tang L, Mao Y, Liu L et al (2009) The volume to be irradiated during selective neck irradiation in nasopharyngeal carcinoma. Cancer 115:680–688

    Article  PubMed  Google Scholar 

  14. Ng WT, Lee MC, Hung WM et al (2011) Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 79:420–428

    Article  PubMed  Google Scholar 

  15. Tham IW, Hee SW, Yeo RM et al (2009) Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy—the National Cancer Centre Singapore experience. Int J Radiat Oncol Biol Phys 75:1481–1486

    Article  PubMed  Google Scholar 

  16. Lee NY, Zhang Q, Pfister DG et al (2012) Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial. Lancet Oncol 13:172–180

    Article  CAS  PubMed  Google Scholar 

  17. Lin S, Lu JJ, Han L et al (2010) Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: experience of 370 consecutive cases. BMC Cancer 10:39

    Article  PubMed Central  PubMed  Google Scholar 

  18. Lin S, Pan J, Han L et al (2009) Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series. Int J Radiat Oncol Biol Phys 75:1071–1078

    Article  PubMed  Google Scholar 

  19. Liu L, Zhang G, Xie C et al (2006) Magnetic resonance imaging of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma: patterns of spread. Int J Radiat Oncol Biol Phys 66:721–730

    Article  PubMed  Google Scholar 

  20. Ho FC, Tham IW, Earnest A et al (2012) Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: a meta-analysis of clinical evidence. BMC Cancer 12:98

    Article  PubMed Central  PubMed  Google Scholar 

  21. Ng S, Chang JT, Chan S et al (2004) Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET. Eur J Nucl Med Mol Imaging 31:1073–1080

    Article  PubMed  Google Scholar 

  22. King AD, Ahuja AT, Leung SF et al (2000) Neck node metastases from nasopharyngeal carcinoma: MR imaging of patterns of disease. Head Neck 22:275–281

    Article  CAS  PubMed  Google Scholar 

  23. Liao X, Mao Y, Liu L et al (2008) How does magnetic resonance imaging influence staging according to AJCC staging system for nasopharyngeal carcinoma compared with computed tomography? Int J Radiat Oncol Biol Phys 72:1368–1377

    Article  PubMed  Google Scholar 

  24. Lengelé B, Hamoir M, Scalliet P et al (2007) Anatomical bases for the radiological delineation of lymph node areas. Major collecting trunks, head and neck. Radiother Oncol 85:146–155

    Article  PubMed  Google Scholar 

  25. Grégoire V, Levendag P, Ang KK et al (2003) CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 69:227–236

    Article  PubMed  Google Scholar 

  26. Atula TS, Varpula MJ, Kurki TJ et al (1997) Assessment of cervical lymph node status in head and neck cancer patients: palpation, computed tomography and low field magnetic resonance imaging compared with ultrasound-guided fine-needle aspiration cytology. Eur J Radiol 25:152–161

    Article  CAS  PubMed  Google Scholar 

  27. King AD, Gary MK, Ahuja AT et al (2004) Necrosis in metastatic neck nodes: diagnostic accuracy of CT, MR imaging, and US1. Radiology 230:720–726

    Article  PubMed  Google Scholar 

  28. Zhang GY, Hu WH, Liu LZ et al (2006) Comparison between PET/CT and MRI in diagnosing lymph node metastasis and N staging of nasopharyngeal carcinoma. Zhonghua Zhong Liu Za Zhi 28:381–384

    CAS  PubMed  Google Scholar 

  29. Chau R, Teo PM, Choi PH et al (2001) Three-dimensional dosimetric evaluation of a conventional radiotherapy technique for treatment of nasopharyngeal carcinoma. Radiother Oncol 58:143–153

    Article  CAS  PubMed  Google Scholar 

  30. Chau R, Teo PM, Kam MK et al (2007) Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord. Med Dosim 32:263–270

    Article  PubMed  Google Scholar 

  31. Yorke ED, Kutcher GJ, Jackson A et al (1993) Probability of radiation-induced complications in normal tissues with parallel architecture under conditions of uniform whole or partial organ irradiation. Radiother Oncol 26:226–237

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We acknowledge the support of the Department of Radiation Oncology. The views expressed in this publication are those of the authors.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xiayun He.

About this article

Cite this article

Chen, J., Ou, D., He, X. et al. Sparing level Ib lymph nodes by intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma. Int J Clin Oncol 19, 998–1004 (2014). https://doi.org/10.1007/s10147-013-0650-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-013-0650-6

Keywords

Navigation